Cabaletta Bio, Inc. - CABA Company Short-Term Debt

Graphic logo of Cabaletta Bio, Inc. (CABA)

The market trend for Cabaletta Bio, Inc. (CABA) shares reflects a dynamic where the separate_debt_short metric stands at 0.02. Quotes are supported by the implementation of energy-efficient technologies in laboratories and adherence to testing ethics. Growth is driven by the engagement of external contractors to scale the early stages of cell product releases. Consequently, Cabaletta Bio, Inc. (CABA) is successfully developing innovative methods for boosting immunity and creating specialized medications.

CABA (Cabaletta Bio Inc.) Company Short-Term Debts history from 07/04/2022 to 10/28/2026

Cabaletta Bio Inc - analytical breakdowns and key metrics (CABA)

- price and consensus price forecast:
Price Chart Cabaletta Bio|CABA - Fair Value Consensus
- market capitalization data:
Market Value Cabaletta Bio|CABA - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Cabaletta Bio, Inc.|CABA - Book Capitalization|Market Cap to Net Assets Ratio cabalettabio.com|CABA - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Cabaletta Bio, Inc.|CABA - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Cabaletta Bio, Inc.|CABA - Company Total Debt|Debt to Book Capitalization Ratio Cabaletta Bio|CABA - Company Long-Term Liabilities|Company Current Liabilities Cabaletta Bio, Inc.
Fundamental company valuation:Cabaletta Bio - CABA
Product sample of Cabaletta Bio, Inc.

For Cabaletta Bio, Inc. (CABA), short-term debt represents the aggregate of obligations maturing within one year. This metric measures current liquidity and the risk of cash flow gaps. By analyzing the short-term debt chart, an investor assesses the company's ability to fund the development of CARTA cells. Debt growth is critical, as business success depends on costly clinical trials. A stable level of obligations confirms financial stability during the scaling of the therapy.

Competitor analysis

Company Short-Term Debt argenx (ARGX)|BNTX: Company Short-Term Loans and Borrowings|ABVX (Abivax) - Company Short-Term Debt|ADMA Corp (ADMA) - Company Current Liabilities|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com (IMVT)|Kiniksa (KNSA) - Company Current Liabilities|Company Short-Term Loans and Borrowings Grifols SA (GRFS)|Company Short-Term Debts ADPT|Celldex Corp - Short-Term Debt Volume|AUPH: Company Short-Term Debt|BCRX: Company Current Liabilities|VERA (Vera Therapeutics) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|PHVS (Pharvaris Corp) - Company Current Liabilities|Company Short-Term Debts ABCL|Company Short-Term Debt Tourmaline Bio, Inc. TRML|Company Short-Term Indebtedness precigen.com (PGEN)|PHAR: Company Short-Term Debts|Short-Term Debt Nektar Therapeutics Inc NKTR|UPB: Company Short-Term Debts|ZBIO - Company Current Liabilities|IMNM: Company Short-Term Debts|gossamerbio.com (GOSS) - Company Short-Term Debts|Company Short-Term Debts KalVista Pharmaceuticals, Inc.|Company Short-Term Debt Septerna, Inc.|Company Short-Term Debts PVLA|Company Short-Term Debts SVRA (Savara Pharma)|Company Short-Term Debt Rigel Pharmaceuticals RIGL|Company Short-Term Debt anaptysbio.com ANAB|ATXS (Astria Therapeutics, Inc.) - Company Short-Term Debts|enGene Holdings Inc (ENGN) - Short-Term Debt|RAPT - Company Current Liabilities|Amount of Current Liabilities Aerovate Therapeutics|Aclaris Therapeutics (ACRS) - Company Current Liabilities|Amount of Current Liabilities kyvernatx.com|Company Short-Term Debts TLSA|Company Short-Term Debts Ventyx Biosciences Inc. VTYX|Company Current Liabilities Theratechnologies Inc|Company Short-Term Loans and Borrowings Avalo Therapeutics Inc AVTX|ELDN - Company Short-Term Debts|AGEN - Company Short-Term Debt|Climb Bio - Company Short-Term Debts|ZURA (zurabio.com) - Short-Term Debt Volume|Company Short-Term Debt ATYR (aTyr)|Short-Term Debt Adagene Corp (ADAG)|ImageneBio Inc (IMA) - Company Current Liabilities|Company Short-Term Loans and Borrowings shattucklabs.com (STTK)|Company Short-Term Debts EQ|Connect Biopharma Holdings - Short-Term Debt Volume|Immunic Inc (IMUX) - Company Short-Term Debt|ATRA - Company Short-Term Indebtedness|IFRX (inflarx.de) - Company Short-Term Debts|Company Current Liabilities x4pharma.com|ACET: Company Current Liabilities|Short-Term Debt Volume Celularity Corp|Company Short-Term Debts INMB (INmune Bio Corp)|Company Current Liabilities Barinthus Biotherapeutics Corp (BRNS)|Company Short-Term Debts KZR (Kezar Life Sciences)|Company Short-Term Debts sabbiotherapeutics.com SABS|AKTX - Company Short-Term Debts|ENLV - Company Short-Term Debt|QTTB: Company Short-Term Debts|GOVX (GeoVax Corp) - Company Short-Term Debts|Company Short-Term Debt Edesa Biotech, Inc. EDSA|Current Liabilities ibioinc.com|Carisma Therapeutics (CARM) - Company Short-Term Debts|Company Short-Term Loans and Borrowings XTL Biopharmaceuticals Ltd (XTLB)|Company Short-Term Debts BOLT (Bolt Biotherapeutics, Inc.)|HCW Biologics, Inc. - Company Short-Term Debts|Company Short-Term Debt Aptevo (APVO)|AIM: Company Short-Term Loans and Borrowings|ADTX (aditxt.com) - Company Short-Term Debt|GRI Bio Inc (GRI) - Company Current Liabilities|XRTX (XORTX) - Company Short-Term Debts|Company Short-Term Debts Vyome Therapeutics (HIND)|Revelation Biosciences (REVB) - Company Current Liabilities|Company Short-Term Loans and Borrowings indaptusrx.com (INDP)|Company Short-Term Debts SCNI|CalciMedica Inc - Short-Term Debt Volume|AFMD: Company Short-Term Debt|ALLK: Company Current Liabilities|HOOK (hookipapharma.com) - Company Short-Term Debt|Company Current Liabilities IGM Biosciences|ITOS (iTeos Therapeutics, Inc.) - Company Current Liabilities|Company Short-Term Debts OCEA|Company Short-Term Debt TC BioPharm (Holdings) PLC TCBP|Company Short-Term Indebtedness Third Harmonic Bio Inc (THRD)